Q2 2025 Earnings Call Transcript August 4, 2025 Axsome Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.92 ...

Axsome Therapeutics reported record total product revenues of $150 million for the quarter, marking a 72% increase year-over-year and a 24% increase quarter-over-quarter. This impressive growth ...

In a report released yesterday, Cerena Chen from Wells Fargo maintained a Buy rating on Axsome Therapeutics, with a price target of $165.00. The company’s shares closed yesterday at $106.54. Take ...

Cannabinoids are specific chemical compounds found in cannabis, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Research is increasingly su ...

The second half of 2025 could be much more favorable for stockpickers looking for the best small-cap stocks to buy.That might ...

The risk for several adverse health outcomes, including PTSD, traumatic brain injury and anxiety, was heightened among active ...

The postoperative pain management market is witnessing steady growth, driven by the rising number of surgical procedures globally and increasing awar ...